ROCHESTER, Mich.,
Sept. 13, 2013 /PRNewswire/ -- OPTIMIZERx Corp. (OTCQB:
OPRX) today announced the launch of OPTIMIZEHR®
the company's Electronic Heath Record (EHR) consulting and
implementation practice.
(Logo:
http://photos.prnewswire.com/prnh/20130913/DE79474LOGO-a )
(Logo:
http://photos.prnewswire.com/prnh/20130913/DE79474LOGO-b )
Building on the growing success of OPTIMIZERx's SampleMD™
eCoupon and eVoucher program, OPTIMIZERx has launched
OPTIMIZEHR®, which is a one-stop EHR strategy and
implementation service for pharmaceutical-biotech brands and the
agencies that advise them. OPTIMIZEHR®
brings together not only OPTIMIZERx's dominant market-leading
distribution reach, totaling over 300 EHRs, but also best-in-class
partners to deliver product information (Physician's Desk
Reference), patient education (Krames/Staywell) and adherence
(DrFirst's Patient Advisor) solutions. OPTIMIZEHR® has
additional pending relationships with other key industry players to
add further solutions and reach to impact more physicians and
patients.
"We are extremely excited to be able to announce the launch of
our OPTIMIZEHR® practice, which provides client
brands and agencies unique insights, expertise and streamlined
implementation for their entire EHR promotional and patient support
strategies," said Shad Stastney,
Chairman and CEO of OPTIMIZERx. "By virtue of the strength of our
team and our partners, combined with the success we've already
proven in reaching healthcare providers through their EHRs, we can
customize and leverage best-in-class solutions to help our clients
reach and assist doctors and patients directly in their EHR
workflow. We're thrilled to now be able to offer our clients
all of the strategies, solutions, training and implementation they
will need to fully access the EHR opportunity through our
OptimizEHR® solution. From understanding the goals
of the clients to developing, training, launching and measuring
innovative programs -- OPTIMIZEHR® will
streamline and optimize our clients' success. We have already
begun to provide these services to key pharmaceutical companies and
we expect this to further differentiate our value within this
exciting, yet complex, digital space."
Additionally, the Company announced its eCoupon and
eVoucher distribution total for August, 2013 was 101,748, which
together with July's total of 110,654, brings total distributions
for the first two months of the third quarter of 2013 to 212,402,
compared to 54,905 during the same two months of
2012. Mr. Stastney stated, "We're gratified to see more
and more patients and their doctors each month benefitting from the
savings delivered by our solutions, and the better adherence and
outcomes that should result from lowering the patient's cost of
getting on and staying on a prescription. We expect that
growth trend will continue, thanks to the increasing recognition of
our value proposition among our pharmaceutical and EHR
clients."
For more information about the company, please go to
www.optimizerxcorp.com or contact us at 248-651-6568. For investor
relations, please contact Chris
Schreiber at Taglich Brothers, Inc. at 917-445-6207.
About OPTIMIZERx Corp
OPTIMIZERx Corp. (OTCQB: OPRX) provides unique consumer and
physician platforms to help patients better afford and comply with
their medicines and healthcare products, while offering
pharmaceutical and healthcare companies effective ways to expand
patient awareness, access and adherence to their medications. For
more information, please go to www.optimizerxcorp.com
'SAFE HARBOR' This press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended and such section 21E of the Securities Act
of 1934, amended. These forward-looking statements should not be
used to make an investment decision. The words 'estimate,'
'possible' and 'seeking' and similar expressions identify
forward-looking statements, which speak only as to the date the
statement was made. The company undertakes no obligation to
publicly update or revise any forward-looking statements, whether
because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition and other material risks.
Contact:
Chris Schreiber
Taglich Brothers, Inc.
917-445-6207
SOURCE OPTIMIZERx Corp.